Company:  PHARMAGREEN BIOTECH INC. (PHBI)
Form Type:  S-1
Filing Date:  5/8/2020 
CIK:  0001435181 
Address:  2987 BLACKBEAR COURT 
City, State, Zip:  COQUITLAM,  V3E3A2 
Telephone:  702-803-9404 
Fiscal Year:  09/30 
Last Trade
Last Trade: 
$0.09  
Change: 
0.015 (21.43%)  
Trade Time: 
03:23 PM EST  
Market Cap: 
$8.14M
Trade PHBI now with

© 2020  
Description of Business
Pharmagreen Biotech Inc. (the "Company") was incorporated under the laws of the State of Nevada on November 26, 2007. The Company is headquartered in Coquitlam, British Columbia. The Company's mission is to advance the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same plantlets of high CBD hemp and other flora and offering full spectrum DNA testing for plant identification, live genetics preservation using low temperature storage for various cannabis and horticulture plants; extraction of botanical oils mainly CBD oil, and to deliver laboratory based services to the North American high CBD hemp, Cannabis and agriculture sectors. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital.
Register and access this filing in:     
  FORM S-1
    CALCULATION OF REGISTRATION FEE
    ABOUT THIS PROSPECTUS
    TABLE OF CONTENTS
    THE OFFERING
    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
    SUMMARY FINANCIAL DATA
      INCOME STATEMENT
      BALANCE SHEET
    RISK FACTORS
    ITEM 6. SELLING SECURITY HOLDERS
      BENEFICIAL OWNERS
    PLAN OF DISTRIBUTION
    ITEM 8. DESCRIPTION OF SECURITIES TO BE REGISTERED
    DESCRIPTION OF CAPITAL STOCK
    DESCRIPTION OF WARRANTS
    ITEM 9. INTERESTS OF NAMED COUNSEL, EXPERTS AND STRATEGIC ...
    LEGAL MATTERS
      ITEM 10. INFORMATION WITH RESPECT TO THE REGISTRANT
    DESCRIPTION OF BUSINESS
      Employees
      Competition
      DESCRIPTION OF PROPERTY
      LEGAL PROCEEDINGS
    MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ...
    Changes In and Disagreements with Accountants on Accounting ...
      NAME AND TITLE
      NAME AND TITLE
    Conflicts of Interest
    Summary Executive Compensation Table
      Stock Awards Plan
    Director Compensation
    Security Holders Recommendations to Board of Directors
      BENEFICIAL OWNERS
    WHERE YOU CAN FIND ADDITIONAL INFORMATION
      BALANCE SHEET
      INCOME STATEMENT
      STOCKHOLDERS EQUITY
      CASH FLOW
      Notes to the Consolidated Financial Statements
        STOCKHOLDERS EQUITY
    PART II
      Item 11. Other Expenses of Issuance and Distribution.
      Item 12. Indemnification of Directors and Officers.
      Item 13. Recent Sales of Unregistered Securities
      Item 14. Undertakings.
      Item 16. Exhibits.
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 23.1